In many cases, tirzepatide prescriptions may be covered by insurance, lowering your out-of-pocket costs significantly
Increases in bone mineral density and linear growth were attenuated in QSYMIA- versus placebo-treated patients [see Warnings and Precautions (5.6)]
Given the theoretical risk observed in animal studies and the seriousness of MTC, these individuals are not typically candidates for treatment through telehealth platforms, where an in-depth, in-person assessment might be more appropriate
The FDA placed it on a Category 2 do-not-compound list in 2023 over impurity and immune-reaction concerns, so no licensed compounding pharmacy can prepare it either
This is an observational, retrospective study, not a prospective randomized trial, Bremner said
Once a shortage is resolved, compounded versions of these drugs become unapproved unless they differ substantially from the FDA-approved originals or meet specific patient needs that branded drugs cannot